Differential Effects of GLP-1 Receptor Agonists on Cancer Risk in Obesity - A Nationwide Analysis of 1.1 Million Patients
Favorite
Share
More Options
17

Open in WPS to view all 17 pages
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
